Study results demonstrate that nafamostat had similar efficacy as citrate, while providing lower toxicity and lower costs to the hospital over standard citrate anticoagulation. HAYWARD, Calif., March 29, 2022 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty...
News Ticker
- [ March 20, 2023 ] New Four-Year Data for Genentech’s Evrysdi Reinforce Long-Term Efficacy and Safety Profile in Some of the Most Severely Affected People With Types 2 and 3 Spinal Muscular Atrophy (SMA) News
- [ March 20, 2023 ] Applied Biomechanics Researcher, Apple Design Team – Apple – Cupertino, CA San Francisco Biotech Jobs
- [ March 19, 2023 ] QC Scientist II – Thermo Fisher Scientific – San Francisco, CA San Francisco Biotech Jobs
- [ March 18, 2023 ] Quality Scientist 4, Microbiology – Johnson & Johnson – Redwood City, CA San Francisco Biotech Jobs
- [ March 18, 2023 ] Sr. Manager, Global Market Development, Genetic Sciences – Thermo Fisher Scientific – Sunnyvale, CA San Francisco Biotech Jobs
Copyright © 2022 Biotech Networks, LLC
